- Home
- NXPL vs CGTX Comparison
NXPL vs CGTX Comparison
Compare NXPL & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- CGTX
- Stock Information
- Founded
- NXPL 1997
- CGTX 2007
- Country
- NXPL United States
- CGTX United States
- Employees
- NXPL N/A
- CGTX N/A
- Industry
- NXPL Telecommunications Equipment
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- NXPL Telecommunications
- CGTX Health Care
- Exchange
- NXPL Nasdaq
- CGTX Nasdaq
- Market Cap
- NXPL 19.5M
- CGTX 16.1M
- IPO Year
- NXPL N/A
- CGTX 2021
- Fundamental
- Price
- NXPL $1.28
- CGTX $0.58
- Analyst Decision
- NXPL
- CGTX Buy
- Analyst Count
- NXPL 0
- CGTX 6
- Target Price
- NXPL N/A
- CGTX $8.00
- AVG Volume (30 Days)
- NXPL 261.3K
- CGTX 18.0M
- Earning Date
- NXPL 11-14-2024
- CGTX 11-13-2024
- Dividend Yield
- NXPL N/A
- CGTX N/A
- EPS Growth
- NXPL N/A
- CGTX N/A
- EPS
- NXPL N/A
- CGTX N/A
- Revenue
- NXPL $66,482,000.00
- CGTX N/A
- Revenue This Year
- NXPL N/A
- CGTX N/A
- Revenue Next Year
- NXPL N/A
- CGTX N/A
- P/E Ratio
- NXPL N/A
- CGTX N/A
- Revenue Growth
- NXPL 179.89
- CGTX N/A
- 52 Week Low
- NXPL $0.71
- CGTX $0.34
- 52 Week High
- NXPL $2.68
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- NXPL 62.10
- CGTX 65.53
- Support Level
- NXPL $0.86
- CGTX $0.43
- Resistance Level
- NXPL $1.31
- CGTX $0.52
- Average True Range (ATR)
- NXPL 0.18
- CGTX 0.09
- MACD
- NXPL 0.05
- CGTX 0.02
- Stochastic Oscillator
- NXPL 79.17
- CGTX 22.40
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.